Comprehensive Test Menu August 2018

Similar documents
Comprehensive Test Menu December 2018

Clinical Cancer Genetics

CentoCancer STRIVE FOR THE MOST COMPLETE INFORMATION

GYNplus. genetic testing for hereditary ovarian and/or uterine cancer

GYNplus: A Genetic Test for Hereditary Ovarian and/or Uterine Cancer

Genetic Risk Assessment for Cancer

Corporate Medical Policy

Neurological Disorders

Informed Consent Columbia Whole Genome or Whole Exome Sequencing

patient guide CancerNext-Expanded genetic testing for hereditary cancer Because knowing your risk can mean early detection and prevention

Whole Exome Sequencing (WES): Questions and Answers for Providers

Genetic Cancer Susceptibility Panels Using Next Generation Sequencing

Genetic Testing for Familial Gastrointestinal Cancer Syndromes. C. Richard Boland, MD La Jolla, CA January 21, 2017

Neurogenetics Genetic Testing and Ethical Issues

WHAT IS A GENE? CHROMOSOME DNA PROTEIN. A gene is made up of DNA. It carries instructions to make proteins.

OncoGeneDx Test Requisition Form

BRCAplus. genetic testing for hereditary breast cancer

Expert Interview: Inherited Susceptibility to Cancer with Dr. Nicoleta Voian

Genetic Cancer Susceptibility Panels Using Next Generation Sequencing. Policy Specific Section: September 27, 2013 January 30, 2015

Populations Interventions Comparators Outcomes Individuals: With a personal and/or family history suggesting an inherited cancer syndrome

Medical Policy Update

A guide to genetic testing for hereditary cancers

Genetic Risk Assessment for Cancer

WHAT IS A GENE? CHROMOSOME DNA PROTEIN. A gene is made up of DNA. It carries instructions to make proteins.

Account # Notes. Physician Name Physician Phone Fax. Diagnosis. CLIA #38D Q11 REQ page 1 of 5

OncoGeneDx Test Requisition Form

patient guide CancerNext genetic testing for hereditary cancer Because knowing your risk can mean early detection and prevention

HEREDITY & CANCER: Breast cancer as a model

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

The benefit of. knowing. Genetic testing for hereditary cancer. A patient support guide

Germline Multigene Panel Testing in Oncology: Genetic Counseling Perspective

Why Test for Hereditary Cancer in Preventive Care?

Genetic Cancer Susceptibility Panels Using Next Generation Sequencing

patient guide BrainTumorNext genetic testing for hereditary brain tumors Because knowing your risk can mean early detection and prevention

Genetic Testing for Hereditary Cancer Susceptibility Syndromes

UNIVERSITY OF PENNSYLVANIA GENETIC DIAGNOSTIC LABORATORY

Information for You and Your Family

The Next Generation of Hereditary Cancer Testing

MOLECULAR SERVICES. mlabs.umich.edu

Myriad Financial Assistance Program (MFAP)

Division of Genomic Diagnostics CANCER GENOMIC TEST REQUISITION Page 1 of 6

Genetic testing and pancreatic disease

GEN ETICS AN D GEN OM ICS IN CANCER PREVENTION AN D TREATM EN T. Robert Nathan Slotnick MD PhD Director, Medical Genetics and Genomics

Are you at risk of Hereditary Cancer? Your Guide to the Answers

COLON CANCER & GENETICS VERMONT COLORECTAL CANCER SUMMIT NOVEMBER 15, 2014

List of diseases covered by Cancer Predisposition NGS panel

Genetic testing for hereditary cancer

A CANCER GENETICIST S (2 ND ) BEST FRIEND IS THEIR PATHOLOGIST. Dr Alan Donaldson Consultant in Clinical Genetics St Michaels Hospital Bristol

OvaNext. patient guide. genetic testing for hereditary breast, ovarian, and uterine cancer

patient guide RenalNext genetic testing for hereditary kidney cancer Because knowing your risk can mean early detection and prevention

Family history of pancreatic cancer

Be Ready Pack Learn more about how Myriad myrisk is revolutionizing hereditary cancer testing.

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK

Chapter 2 Cancer and Genetic Counseling

UNIVERSITY OF PENNSYLVANIA GENETIC DIAGNOSTIC LABORATORY. Name of Test Turnaround Time Cost CPT codes

Learn your genetic risk for the most common hereditary cancers.

Hereditary Aspects of Pancreatic Cancer


Hereditary Cancer Update Strengthening Linkages Workshop April 22, 2017

SYSTEMATIC ASSESSMENT OF CLINICAL ACTIONABILITY ASSOCIATED WITH GENOMIC VARIATION

Hereditary Cancer Risk Assessment for Gynecological Cancers. FarrNezhatMD.com

Hereditary Gastric Cancer

TECHNICAL NOTICE. The CPT coding in this notice is effective January 1, 2013 and replaces the coding currently in use for these assays

10/21/ New Release, Quest Diagnostics Nichols Institute, Valencia

GHUK BowelGene_2017.qxp_Layout 1 22/02/ :22 Page 3 BowelGene

Cancer Genomics 101. BCCCP 2015 Annual Meeting

A Patient s Guide to Hereditary Cancer. Is Hereditary Cancer Testing Right for You?

Hereditary Cancer Update: What do GPOs need to know?

Hereditary Cardiovascular Conditions

Hereditary Cancer Products

Phosphorus. Diagnostics

Germline Testing for Hereditary Cancer with Multigene Panel

BowelGene. How do I know if I am at risk? Families with hereditary bowel cancer generally show one or more of the following clues:

Multigene Panel Testing for Hereditary Cancer Risk

patient guide PancNext genetic testing for hereditary pancreatic c a ncer Because knowing your risk can mean early detection and prevention

Hereditary Breast and Ovarian Cancer Rebecca Sutphen, MD, FACMG

Objectives. Genetics in Cancer Treatment and Prevention. Genes

DNA Genetic Cancer Risk Test. Test Report

Hereditary Cancer Syndromes

ERN: GENTURIS Gene-c Tumour Risk Syndromes

Genomic Medicine in Oncology

Test Information Sheet

PROVIDER POLICIES & PROCEDURES

Enabling Personalized

Genetic Testing and Counseling for Inherited Cancer Syndromes. Proportion of inherited cancers. Sources. Objectives

ACG Clinical Guideline: Genetic Testing and Management of Hereditary Gastrointestinal Cancer Syndromes

Versus. Cancer genomics Competitive Analysis

patient guide BreastNext genetic testing for hereditary breast cancer Because knowing your risk can mean early detection and prevention

Prices listed correspond to institutional rates only; please contact the lab for insurance rates.

GeneHealth BreastGene_New qxp_Layout 1 21/02/ :42 Page 3 BreastGene GeneHealth UK

Genetic Testing: who, what, why?

6/8/17. Genetics 101. Professor, College of Medicine. President & Chief Medical Officer. Hereditary Breast and Ovarian Cancer 2017

Prices listed correspond to institutional rates only; please contact the lab for insurance rates.

11/29/2017. Genetics and Cancer ERICA L SILVER, MS, LCGC GENETIC COUNSELOR. Genetics 101. Transcription vs Translation

Yes when meets criteria below. Dean Health Plan covers when Medicare also covers the benefit.

Prior Authorization. Additional Information:

Comprehensive Test Requisition Form - Page 1 of 6

Transcription:

Comprehensive Test Menu August 2018 Cancer brain tumors Brain tumors, hereditary BrainTumorNext: 27 genes 14-21 days 8847 Neurofibromatosis type 2 (NF2) NF2 14-21 days 9024 Schwannomatosis SMARCB1 14-21 days 7180 breast and gynecologic cancer Ataxia-telangiectasia ATM 14-21 days 9014 Breast cancer, hereditary BRCA1/BRCA2 6-10 days 8838 BRCA Ashkenazi Jewish 3-site mutation panel 6-10 days 5892 BRCAplus: 8 genes 7-10 days 8836 BreastNext: 17 genes 14-21 days 8820 CHEK2-related cancer CHEK2 14-21 days 9016 Li-Fraumeni syndrome TP53 14-21 days 2866 Ovarian and uterine cancer, hereditary GYNplus: 13 genes 14-21 days 8835 Ovarian, breast and uterine cancer, hereditary OvaNext: 25 genes 14-21 days 8830 Ovarian cancer, paired tumor/germline TumorNext-HRD 21-28 days 9811 TumorNext-BRCA 21-28 days 9810 PALB2-associated cancer PALB2 14-21 days 2366 PTEN-related disorders (Cowden syndrome, Proteus syndrome, macrocephaly and autism) PTEN 14-21 days 2106 comprehensive cancer Breast, ovarian, colorectal, uterine and other cancer CancerNext: 34 genes 14-21 days 8824 CancerNext-Expanded: 67 genes 14-21 days 8874 CustomNext-Cancer: choose up to 81 genes 14-21 days 9510 endocrine tumors Multiple endocrine neoplasia type 1 (MEN1) MEN1 14-21 days 2646 Multiple endocrine neoplasia type 2 (MEN2) and familial medullary thyroid cancer (FMTC) Paraganglioma (PGL) and pheochromocytoma (PCC), hereditary RET 14-21 days 2680 PGLNext: 12 genes 14-21 days 5504 1

gastrointestinal cancer Adenomatous polyposis APC, MUTYH 14-21 days 8726 Colorectal cancer, hereditary ColoNext: 17 genes 14-21 days 8822 Familial adenomatous polyposis (FAP) APC 14-21 days 3040 Gastric cancer, hereditary diffuse (HDGC) CDH1 10-21 days 4726 Juvenile polyposis syndrome (JPS) BMPR1A, SMAD4 14-21 days 8604 Lynch syndrome (formerly hereditary non-polyposis colorectal cancer or HNPCC) - germline only MLH1, MSH2, MSH6, PMS2, EPCAM 14-21 days 8517 Lynch syndrome, paired tumor/germline TumorNext-Lynch 21-28 days 8980 MUTYH-associated polyposis (MAP) MUTYH 14-21 days 4661 Pancreatic cancer, hereditary PancNext: 13 genes 14-21 days 8042 Peutz-Jeghers syndrome (PJS) STK11 14-21 days 2766 genitourinary cancer Birt-Hogg-Dubé syndrome (BHDS) FLCN 14-21 days 5921 Hereditary leiomyomatosis and renal cell carcinoma (HLRCC) FH 14-21 days 6301 Kidney cancer, hereditary RenalNext: 18 genes 14-21 days 5900 Prostate cancer, hereditary ProstateNext: 14 genes 14-21 days 8845 von Hippel-Lindau disease (VHL) VHL 14-21 days 2606 skin cancer/melanoma Malignant melanoma, hereditary CDKN2A, CDK4 14-21 days 4708 MelanomaNext: 8 genes 14-21 days 8849 Nevoid basal cell carcinoma syndrome (NBCCS)/ Gorlin syndrome PTCH1 14-21 days 5684 other individual hereditary cancer conditions Li-Fraumeni syndrome TP53 10-21 days 2866 Neurofibromatosis type 1 (NF1) NF1 14-21 days 5704 Pleuropulmonary blastoma and DICER1- related disorders DICER1 14-21 days 5260 PTEN-related disorders (Cowden syndrome, Proteus syndrome, macrocephaly and autism) PTEN 14-21 days 2106 Retinoblastoma, hereditary RB1 14-21 days 5426 Tuberous sclerosis complex (TSC) TSC1, TSC2 14-21 days 5904 2

Cardiology Arrhythmias and cardiomyopathy, inherited CardioNext 2-3 weeks 8911 CustomNext-Cardio: Choose up to 106 genes 2-3 weeks 9520 Arrhythmias, inherited (long QT syndrome, Brugada syndrome, and others) RhythmFirst: 12 genes 2-3 weeks 8888 RhythmNext: 36 genes 2-3 weeks 8900 Arrhythmogenic right ventricular cardiomyopathy (ARVC) RhythmFirst reflex RhythmNext 2-3 weeks 8901 ARVCNext 2-3 weeks 8904 Cardiomyopathy, inherited CMNext 2-3 weeks 8887 Catecholaminergic polymorphic ventricular tachycardia (CPVT) CPVTNext: 6 genes 2-3 weeks 8902 Dilated cardiomyopathy (DCM) DCMNext: 36 genes 2-3 weeks 8884 Familial hypercholesterolemia (FH) FHNext: APOB, LDLR, LDLRAP1, PCSK9 and SLC01B1 (c.521t>c) 2-3 weeks 8680 Familial transthyretin amyloidosis TTR 2-3 weeks 1560 Hypertrophic cardiomyopathy (HCM) HCMFirst: MYBPC3, MYH7 2-3 weeks 8935 connective tissue related disorders HCMNext: 27 genes 2-3 weeks 8936 HCMFirst reflex HCMNext 2-3 weeks 8883 Ehlers-Danlos, vascular type (EDS IV) COL3A1 2-3 weeks 8790 COL3A1 reflex TAADNext 2-3 weeks 8791 Marfan syndrome (MFS) FBN1 2-3 weeks 8781 FBN1 reflex TAADNext 2-3 weeks 8783 Marfan syndrome, thoracic aortic aneurysms and related disorders TAADNext: 22 genes 2-3 weeks 8789 3

Clinical Genomics Karyotype High resolution 1-3 weeks 3660 High resolution, rule out mosaic 1-3 weeks 3662 Chromosomal microarray analysis SNP Array 2-3 weeks 5490 Familial Targeted Microarray 2-3 weeks 5495 Exome Sequencing ExomeNext-Proband 6-8 weeks 9993 ExomeNext-Proband plus mtdna 6-8 weeks 9994 ExomeNext-Trio 6-8 weeks 9995 ExomeNext-Trio plus mtdna 6-8 weeks 9996 ExomeNext-Select: Choose up to 500 genes 6-8 weeks 9500 ExomeNext-Rapid 8 days (verbal) 14 days (full report) 9999R Exome sequencing only - Raw data 4-6 weeks 9997 Exome sequencing only - Raw data + Filtered Variant List 4-6 weeks 9998 Endocrinology Hereditary leiomyomatosis and renal cell carcinoma FH 14-21 days 6301 Maturity-onset diabetes of the young (MODY) HNF1A, HNF4A, HNF1B, GCK, PDX1 4-5 weeks 8310 Multiple endocrine neoplasia type I (MEN1) MEN1 14-21 days 2646 Multiple endocrine neoplasia type 2 (MEN2) and familial medullary thyroid cancer (FMTC) RET 14-21 days 2680 Neurofibromatosis type 1 (NF1) NF1 14-21 days 5704 Paraganglioma (PGL) and pheochromocytoma (PCC), hereditary PGLNext: 12 genes 14-21 days 5504 von Hippel-Lindau disease (VHL) VHL 14-21 days 2606 4

Gastroenterology Cystic fibrosis 508 FIRST: deltaf508 mutation, reflex to Duplicaton Analysis Duplication Analysis (concurrent) 5-13 days 1002 5-13 days 1007 Hirschsprung disease (RET-related) RET 14-21 days 2680 Juvenile polyposis syndrome (JPS) BMPR1A, SMAD4 14-21 days 8604 Pancreatitis CASR, CFTR, CPA1, CTRC, PRSS1, SPINK1 14-28 days 8022 Peutz-Jeghers syndrome STK11 10-21 days 2766 Hematology/Oncology Diamond-Blackfan anemia DBANext: 11 genes 14-28 days 8550 Dyskeratosis congenita DCNext: 7 genes 14-28 days 8161 Shwachman-Diamond syndrome (SDS) SBDS 14-28 days 1440 Multiple Congenital Anomalies CHARGE syndrome CHD7 2-4 weeks 2380 Cornelia de Lange syndrome CdLSNext: NIPBL, SMC1A, HDAC8, RAD21, SMC3 2-3 weeks 7040 Noonan syndrome PTPN11, SOS1, RAF1, KRAS 2-3 weeks 8402 5

Neurology Comprehensive neurology testing CustomNext-Neuro: Choose up to 196 genes 2-3 weeks* 9540 *Orders with >140 genes will have a TAT of 4-6 weeks epilepsy Comprehensive epilepsy testing EpilepsyNext: 100 genes 2-3 weeks 7019 Rapid epilepsy testing EpiRapid: 16 genes 10-14 days 7033 EpiRapid reflex EpilepsyNext 2-3 weeks 7034 Familial Hemiplegic Migraine FHM: 4 genes 2-3 weeks 7035 Febrile seizures EpiFirst-Fever: 13 genes 2-3 weeks 7011 Infantile spasms EpiFirst-IS: 17 genes 2-3 weeks 7013 Tuberous sclerosis complex: TSC1, TSC2 2-3 weeks 5904 Non-lesional focal epilepsy EpiFirst-Focal: 11 genes 2-3 weeks 7017 hereditary neuropathy Familial transthyretin amyloidosis TTR 2-3 weeks 1560 neurocutaneous/neuro-oncology disorders Ataxia-telangiectasia ATM 2-3 weeks 9014 Brain tumors, hereditary BrainTumorNext: 27 genes 2-3 weeks 8847 Hereditary hemorrhagic telangiectasia (HHT) HHTNext: ACVRL1, ENG, GDF2, RASA1, SMAD4 2-3 weeks 8672 Legius syndrome SPRED1 2-3 weeks 5724 Li-Fraumeni syndrome TP53 2-3 weeks 2866 Neurofibromatosis 1 (NF1) NF1 2-3 weeks 5704 Neurofibromatosis 2 (NF2) NF2 2-3 weeks 9024 Nevoid basal cell carcinoma syndrome (NBCCS)/Gorlin syndrome PTCH1 2-3 weeks 5684 Schwannamatosis SMARCB1 2-3 weeks 7180 Tuberous sclerosis complex (TSC) TSC1, TSC2 2-3 weeks 5904 von Hippel-Lindau disease (VHL) VHL 2-3 weeks 2606 6

neurodevelopmental disorders Autism spectrum disorders AutismNext: 48 genes 2-3 weeks 7024 Autism spectrum disorders, epilepsy, intellectual disability PTEN 1-3 weeks 2106 Neurodevelopment-Expanded: 196 genes 4-6 weeks 7028 Fragile X syndrome (Trinucleotide repeat analysis) FMR1 1-2 weeks 4544 Intellectual disability IDNext: 140 genes 2-3 weeks 7027 Rett syndrome MECP2 2-3 weeks 2026 Pulmonology Congenital central hypoventilation syndrome (CCHS) PHOX2B 2-4 weeks 1580 Cystic fibrosis 508 FIRST: deltaf508 mutation, reflex to Duplicaton Analysis Duplication Analysis (concurrent) 5-13 days 1002 5-13 days 1007 Primary ciliary dyskinesia (PCD) PCDNext: 21 genes 4-5 weeks 8122 Surfactant dysfunction (respiratory distress syndrome) ABCA3, SFTPB, SFTPC 5-14 days 8100 Telomere-related pulmonary fibrosis TERT, TERC 2-4 weeks 8140 Vascular Ehlers-Danlos, vascular type (EDS IV) COL3A1 2-3 weeks 8790 COL3A1 reflex TAADNext 2-3 weeks 8791 Hereditary hemorrhagic telangiectasia (HHT) HHTNext: ACVRL1, ENG, GDF2, RASA1, SMAD4 2-3 weeks 8672 Marfan syndrome (MFS) FBN1 2-3 weeks 8781 FBN1 reflex TAADNext 2-3 weeks 8783 Thoracic aortic aneurysms TAADNext: 22 genes 2-3 weeks 8689 Other Test Name/Gene(s) Test Code MCC for amniotic fluid culture or CVS 1260 MCC reference for maternal blood sample 1262 Additional testing options like Gene Sequence Analysis, Deletion/Duplication Analysis, or Single Site Analysis may be available. Various reflex options between 50339.1498_v36 08.22.18 7 Argonaut, Aliso Viejo, CA 92656 USA Toll Free +1.866.262.7943 Fax +1.949.900.5501 ambrygen.com 7